Suggestions

Du même auteur

Proposals for managing patients with thoracic malignancies during COVID-19 pandemic

Archive ouverte | Girard, N. | CCSD

International audience

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Archive ouverte | Griesinger, F. | CCSD

International audience

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

Archive ouverte | Belli, C. | CCSD

International audience. Aberrant activation of RET is a critical driver of growth and proliferation in diverse solid tumours. Multikinase inhibitors (MKIs) showing anti-RET activities have been tested in RET-altered...

Chargement des enrichissements...